DiaMonTech logo
Startup

DiaMonTech

See DiaMonTech's full profile

BOOK A DEMO
Headquarters

Germany

Founded Year

2019

Total Funding

$7.7M

Employees

11 - 50

Status

Active


About DiaMonTech

Awarded for “most innovative German startup” from German business magazine Bilanz, DiaMonTech has developed a medical device that non-invasively measures your blood glucose without finger pricking, a drop of blood, or a test strip.

Headquarters

Boxhagener Straße 82 a, 10245 Berlin, Germany


General Information on DiaMonTech

Brand name DiaMonTech
Company name DiaMonTech AG
Register number HRB 212017
Website https://www.diamontech.de/
Founded year 2019
Employees 11 - 50
Founding team

Thorsten Lubinski

Sergius Janik

Contact [email protected]

Find startup solutions in your specific business context

The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
BOOK A DEMO

Recent News and Activity about DiaMonTech

Drug Delivery Business News 18.02.2022
DiaMonTech raises $5M for laser-based blood glucose detection system

Berlin, Germany-based DiaMonTech develops a patented, mid-infrared technology platform designed to enable non-invasive blood glucose measurement using a pain-free laser-based detection that has ease of use comparable to the fingerprint sensor on a smartphone. The company aims for the platform to represent a groundbreaking new offering that allows for the management of blood glucose levels without finger pricking, needles and test strips. ...

DiaMonTech news
Ein Presswire 07.01.2022
Non-invasive Blood Glucose Monitoring Devices Market is Rapid to Grow at a 35.0% CAGR by 2028 | DiaMonTech GmbH

SEATTLE, UNITED STATES, UNITED STATES, January 7, 2022 / EINPresswire.com / -- New Research Study " Non-Invasive Blood Glucose Monitoring Devices Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook" has been added to Coherent Market Insights. Rising pervasiveness and rate of diabetes around the world, alongside expanding innovative work (R&D) ...

DiaMonTech news